{
  "ticker": "VRTX",
  "year": 2022,
  "quarter": 2,
  "last_updated": "2025-04-15T14:01:53.509490",
  "count": 89,
  "transactions": [
    {
      "id": 7,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 8239,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 22094,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 42950,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 5,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 8237,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 22092,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 42942,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 3,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 8233,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 22088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 42936,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 42958,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1672",
      "transaction_price": "0.00",
      "transaction_type": "G",
      "shares_after_transaction": "11052"
    },
    {
      "id": 1,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 6,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 17,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 8228,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 8238,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 8254,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 22083,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 22093,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 22112,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 42928,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 42948,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 42994,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 9,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 8241,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 22096,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 42952,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 2,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 12,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 16,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 18,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 8230,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 8246,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 8250,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 8255,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 22085,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 22103,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 22107,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 22114,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 42933,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 42974,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 42985,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 42996,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 4,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 8,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 21,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 25,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 27,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 8235,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 8240,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 8258,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 8270,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 8272,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 22090,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 22095,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 22117,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 22134,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 22136,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 42938,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 42951,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 43005,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 43040,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 43045,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 11,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 23,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 24,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 8244,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 8264,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 8269,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 22101,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 22127,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 22133,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 42967,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 43022,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 43037,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 15,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 8249,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 22106,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 42983,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 10,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 8243,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 22100,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 42963,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 26,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-14",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 8271,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-14",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 22135,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-14",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 43044,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-14",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    }
  ]
}